Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 54 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 7491798

    Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted
  2. US 7488804

    Modified fusion molecules for treatment of allergic disease

    The Regents of the University of California · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted
  3. US 7473525

    Compositions and methods for inhibiting expression of anti-apoptotic genes

    Alnylam Europe AG · Granted Jan 6, 2009 · Expires Jan 1, 2029

    granted
  4. US 7468394

    Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation

    Amphastar Pharmaceuticals, Inc. · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted
  5. US 7468379

    Inhibition of osteolytic lesions by SRC kinase inhibitors

    The Board of Regents of the University of Texas System · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted
  6. US 7449570

    Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

    PTC THERAPEUTICS, INC. · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  7. US 7427389

    Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes

    Provectus Pharmatech, Inc. · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted
  8. US 7423142

    Compositions and methods for inhibiting expression of anti-apoptotic genes

    Alnylam Pharmaceuticals, Inc. · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted
  9. US 7420100

    Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

    The Board of Regents of the University of Texas System · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  10. US 7410363

    Electrical connector having compliant biasing device

    Hon Hai Precision Ind. Co., Ltd. · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  11. US 7407658

    Vaccines for blocking transmission of plasmodium vivax

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted
  12. US 7405233

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted
  13. US 7399612

    VEGF-binding fusion proteins and nucleic acids encoding the same

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted
  14. US 7396682

    Method for cell adhesion and wound healing

    REGENBiotech, Inc. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted
  15. US 7396664

    VEGF-binding fusion proteins and nucleic acids encoding the same

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted
  16. US 7396918

    IGF-I fusion polypeptides and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted
  17. EP 1938801

    Nanoemulsion

    BIOFRONTERA BIOSCIENCE GMBH [DE] · Granted Jul 2, 2008 · Expires Jun 27, 2028

    granted
  18. US 7393544

    Dispersion for pulmonary delivery of a bioactive agent

    Nektar Therapeutics · Granted Jul 1, 2008 · Expires Jun 26, 2028

    granted
  19. US 7378273

    Expression vectors

    Gala Design, Inc. · Granted May 27, 2008 · Expires May 22, 2028

    granted
  20. US 7371821

    Cloning and expression of the full length 110 kDa antigen of Orientia tsutsugamushi to be used as a vaccine component against scrub typhus

    United States of America as represented by the Secretary of the Air Force · Granted May 13, 2008 · Expires May 8, 2028

    granted
  21. US 7368114

    Fusion protein including of CD4

    The United States of America, as represented by the Department of Health and Human Services · Granted May 6, 2008 · Expires May 1, 2028

    granted
  22. US 7368279

    Three dimensional bioengineered smooth muscle tissue and sphincters and methods therefor

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 6, 2008 · Expires May 1, 2028

    granted
  23. US 7368106

    Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state

    The United States of America, as represented by the Department of Health and Human Services · Granted May 6, 2008 · Expires May 1, 2028

    granted
  24. US 7354578

    Method of tumor regression with VEGF inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted